Athina Markou Selected Research

Athina Markou Research Topics

Disease

24	Schizophrenia (Dementia Praecox) 01/2018 - 06/2002
24	Tobacco Use Disorder (Nicotine Dependence) 01/2017 - 07/2003
22	Neoplasms (Cancer) 11/2022 - 10/2002
14	Substance-Related Disorders (Drug Abuse) 10/2014 - 07/2002
13	Anhedonia 01/2018 - 12/2003
12	Hypertension (High Blood Pressure) 01/2022 - 04/2011
12	Circulating Neoplastic Cells 05/2020 - 03/2011
10	Hyperaldosteronism (Conn Syndrome) 03/2021 - 10/2005
10	Cognitive Dysfunction 11/2015 - 01/2009
8	Adenoma (Adenomas) 03/2021 - 12/2009
8	Breast Neoplasms (Breast Cancer) 02/2021 - 10/2011
8	Neoplasm Metastasis (Metastasis) 07/2016 - 01/2012
5	Cocaine-Related Disorders (Cocaine Addiction) 05/2014 - 11/2005
4	Mental Disorders (Mental Disorder) 10/2015 - 06/2002
4	Pain (Aches) 09/2013 - 11/2011
3	Melanoma (Melanoma, Malignant) 10/2020 - 03/2011
3	Pheochromocytoma 10/2017 - 04/2011
3	Carcinogenesis 01/2016 - 10/2008
3	Essential Hypertension 08/2015 - 11/2011
3	Hyperplasia 05/2015 - 01/2006
3	Memory Disorders (Memory Loss) 10/2014 - 11/2012
3	Cushing Syndrome 07/2010 - 04/2005
2	Prostatic Neoplasms (Prostate Cancer) 05/2020 - 01/2018
2	Morbid Obesity 01/2020 - 01/2006
2	Mood Disorders (Mood Disorder) 01/2017 - 10/2014
2	Mania (Manias) 01/2017 - 03/2011
2	Lung Neoplasms (Lung Cancer) 01/2016 - 10/2011
2	Ataxia (Dyssynergia) 09/2015 - 12/2012
2	HIV Infections (HIV Infection) 01/2015 - 07/2014
2	Stroke (Strokes) 10/2014 - 09/2013
2	Epilepsy (Aura) 10/2014 - 09/2013
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2013 - 10/2011
2	Insulin Resistance 11/2012 - 07/2011
2	Psychotic Disorders (Schizoaffective Disorder) 10/2012 - 03/2011
2	Neurobehavioral Manifestations 03/2012 - 09/2007
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 10/2010 - 05/2009
1	Paraproteinemias (Monoclonal Gammopathy) 11/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2022
1	Monoclonal Gammopathy of Undetermined Significance 11/2022
1	COVID-19 01/2022
1	Hyperkalemia 06/2020

Drug/Important Bio-Agent (IBA)

28	Nicotine FDA Link 01/2017 - 06/2002
19	Glutamic Acid (Glutamate)FDA Link 01/2018 - 05/2004
16	Pharmaceutical PreparationsIBA 01/2016 - 06/2002
14	AldosteroneIBA 01/2022 - 10/2005
8	gamma-Aminobutyric Acid (GABA)IBA 01/2017 - 03/2004
8	MicroRNAs (MicroRNA)IBA 07/2016 - 10/2008
7	Phencyclidine (Angel Dust)IBA 01/2018 - 05/2004
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2018 - 03/2007
7	Dopamine (Intropin)FDA LinkGeneric 01/2018 - 05/2007
7	Biomarkers (Surrogate Marker)IBA 07/2016 - 10/2011
7	Clozapine (Clozaril)FDA LinkGeneric 03/2012 - 12/2003
7	Antipsychotic Agents (Antipsychotics)IBA 03/2012 - 01/2007
6	Adrenocorticotropic Hormone (ACTH)FDA Link 12/2016 - 04/2005
6	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 04/2015 - 04/2004
5	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2017 - 10/2005
5	Methamphetamine (Desoxyn)FDA LinkGeneric 07/2015 - 03/2011
5	Cocaine (Cocaine HCl)IBA 03/2013 - 01/2010
5	Amphetamine (Amfetamine)FDA LinkGeneric 10/2010 - 12/2003
4	Epithelial Cell Adhesion MoleculeIBA 02/2021 - 03/2013
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2008
4	Aminobutyrates (Aminobutyric Acid)IBA 10/2015 - 03/2012
4	N-Methylaspartate (NMDA)IBA 10/2014 - 03/2007
4	Antidepressive Agents (Antidepressants)IBA 10/2014 - 01/2005
4	Neurotransmitter Agents (Neurotransmitter)IBA 06/2013 - 10/2008
4	GABA-B ReceptorsIBA 05/2011 - 12/2005
3	Cell-Free Nucleic AcidsIBA 11/2022 - 10/2019
3	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 10/2011
3	Circulating Tumor DNAIBA 10/2020 - 01/2019
3	ReninIBA 07/2016 - 10/2005
3	LY 379268IBA 09/2015 - 09/2013
3	Cholinergic Agents (Cholinergics)IBA 03/2012 - 05/2004
3	GABA-B Receptor AgonistsIBA 05/2011 - 03/2004
3	metabotropic glutamate receptor 2IBA 01/2011 - 08/2010
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 08/2010 - 01/2007
2	Indicators and Reagents (Reagents)IBA 01/2022 - 12/2012
2	SaltsIBA 06/2020 - 05/2012
2	Mineralocorticoid Receptor AntagonistsIBA 06/2020 - 08/2015
2	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 10/2017 - 04/2011
2	N- (bicyclo(2.2.1)hept- 2- yl)- 2- methyl- 5- (4- (trifluoromethyl)phenyl)- 4- pyrimidinamineIBA 01/2017 - 10/2015
2	Insulin (Novolin)FDA Link 10/2015 - 03/2010
2	TolueneIBA 09/2015 - 12/2012
2	Ethanol (Ethyl Alcohol)IBA 06/2014 - 03/2013
2	Glutamate Receptors (Glutamate Receptor)IBA 03/2013 - 10/2004
2	Glucose (Dextrose)FDA LinkGeneric 11/2012 - 07/2011
2	Bupropion (Wellbutrin)FDA LinkGeneric 05/2007 - 11/2003
1	Immunoglobulin M (IgM)IBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	WastewaterIBA 01/2022
1	Ion Channels (Ion Channel)IBA 03/2021
1	Estrogen ReceptorsIBA 02/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2020

Therapy/Procedure

18	Therapeutics 01/2021 - 05/2004
9	Self Administration (Administration, Self) 01/2017 - 07/2003
4	Adrenalectomy 10/2017 - 01/2006
3	Self Medication 11/2015 - 05/2004
3	Drug Therapy (Chemotherapy) 01/2014 - 11/2005
1	Mammaplasty (Breast Reconstruction) 02/2021